Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients

NCT ID: NCT05719766

Last Updated: 2023-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-01

Study Completion Date

2027-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to prospectively explore the effect of incentive-integrated E-IBD (electronic inflammatory bowel disease) chronic disease management model on the improvement of IBD quality of life, and provide a more effective chronic disease management model for improving the quality of life and social participation of IBD patients.The investigators firstly identify the IBD patients in need of empowerment disease activities through the questionnaire .Then, the investigators feedback the patients' education content according to their needs found.Based on the social support network of patient organization and the medical support network of tertiary medical institutions, the investigators complete the empowerment process of IBD patients' self-management initiative and self-management ability, through the internet. Finally ,the investigators evaluate the quality of life(QoL), social participation,disease self-management level via questionnaire . The primary outcome is the improvement of QoL score after three months' intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine follow-up group

Group Type NO_INTERVENTION

No interventions assigned to this group

IBD Disease Management Research Group

Group Type EXPERIMENTAL

education ,psycological support and social support

Intervention Type OTHER

we would give targeted-education according to our patients' need(reflected via questionnaire; we would provide psycological and social support to patients based on their need reflected by questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

education ,psycological support and social support

we would give targeted-education according to our patients' need(reflected via questionnaire; we would provide psycological and social support to patients based on their need reflected by questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.Clinically diagnosed IBD patients,according to the criteria of the Inflammatory Bowel Group of the Gastroenterology Branch of the Chinese Medical Association in 2018;
* 2.Aged 18 to 75 years old;
* 3.Understand and comply with the requirements of the program and sign informed consent.
* 4.Identified as need intervention according to the patient identification questionnaire screening;
* 5.Patients with the ability to complete all course training and/or follow-up work;
* 6.Enrolled at least one year ahead of end of this study(for garantee of enough folllow-up time).

Exclusion Criteria

* 1.Unable or unwilling to sign the consent form, or unable to follow the research procedure;
* 2.Patients who have had a stoma or ileorectal anastomosis (partial scales are not available);
* 3.Patients who do not complete training on time or do not complete follow-up assessments in their entirety;
* 4.Patients with other malignancies or life-threatening complications;
* 5.Pregnancy or lactation;
* 6.Patients whose remaining follow-up time less than one year before the end of this study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yan chen

Role: STUDY_CHAIR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center of Inflammatory Bowel Disease, Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, , China

Site Status

Department of Gastroenterology, Huzhou Central Hospital

Huzhou, , China

Site Status

Department of Gastroenterology, Ruijin Hospital

Shanghai, , China

Site Status

Department of Gastroenterology, Shaoxing Central Hospital

Shaoxing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yan chen, PhD, MD

Role: CONTACT

+8613757118653

Shiyuan Lu, PhD

Role: CONTACT

+8618868110373

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yan chen, PhD,MD

Role: primary

+8613757118653

Jiang Liu, PhD

Role: primary

Jie Zhong, PhD,MD

Role: primary

Yazhen Zhan, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Tiles-Sar N, Neuser J, de Sordi D, Baltes A, Preiss JC, Moser G, Timmer A. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2025 Apr 17;4(4):CD006913. doi: 10.1002/14651858.CD006913.pub3.

Reference Type DERIVED
PMID: 40243391 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20230049

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CMTS0929 for Inflammatory Bowel Disease
NCT06844708 NOT_YET_RECRUITING EARLY_PHASE1
Telemonitoring for IBD Goodness Examination in Russia
NCT05994716 ENROLLING_BY_INVITATION NA